Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Annals of Clinical Biochemistry

• Publication date

  2010-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1258/acb.2009.009172PMID 19969595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efavirenz treatment and false-positive results in benzodiazepine screening tests.

  2009cited by this paper
• Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: problems in routine practice

  2009cited by this paper
• Quantitation of benzodiazepines in urine, serum, plasma, and meconium by LC-MS-MS.

  2008cited by this paper
• Cross-reactivity of nefopam and its metabolites with benzodiazepine EMIT immunoassay.

  2008cited by this paper
• Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis.

  2008cited by this paper
• Simultaneous analysis of thirty-five benzodiazepines in urine using liquid chromatography-mass spectrometry-time of flight.

  2008cited by this paper
• Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).

  2006cited by this paper
• Liquid chromatography-tandem mass spectrometry for detection of low concentrations of 21 benzodiazepines, metabolites, and analogs in urine: method with forensic applications.

  2006cited by this paper
• Interference By Venlafaxine Ingestion in the Detection of Tramadol By Liquid Chromatography Linked to Tandem Mass Spectrometry for the Screening of Illicit Drugs in Human Urine

  2006cited by this paper
• Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification.

  2004cited by this paper
• Criteria for the identification of compounds by liquid chromatography–mass spectrometry and liquid chromatography–multiple mass spectrometry in forensic toxicology and doping analysis

  2003cited by this paper
• Ion suppression in mass spectrometry.

  2003cited by this paper
• Longitudinal study on the prevalence of benzodiazepine (mis)use in a prison: importance of the analytical strategy.

  2003cited by this paper
• Progress of Liquid Chromatography–Mass Spectrometry in Clinical and Forensic Toxicology

  2002cited by this paper
• Simultaneous determination of fifteen low-dosed benzodiazepines in human urine by solid-phase extraction and gas chromatography-mass spectrometry.

  2001cited by this paper
• High-throughput bioanalytical LC/MS/MS determination of benzodiazepines in human urine: 1000 samples per 12 hours.

  1999cited by this paper
• The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.

  1997cited by this paper
• Screening, identification, and quantitation of benzodiazepines in postmortem samples by HPLC with photodiode array detection.

  1995cited by this paper
• False-positive immunoassay results for urine benzodiazepine in patients receiving oxaprozin (Daypro).

  1995cited by this paper
• Urinary screening for benzodiazepines with radioreceptor assay: comparison with EMIT d.a.u. benzodiazepine assay and high-performance liquid chromatography.

  1994cited by this paper
• Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry.

  1994cited by this paper
• False-positive results from the Syva EMIT d.a.u. monoclonal amphetamine assay as a result of antipsychotic drug therapy.

  1993cited by this paper
• Mefenamic acid prevents assessment of drug abuse with EMIT assays.

  1993cited by this paper
• Comparative studies on the detection of benzodiazepines in serum by means of immunoassays (FPIA).

  1993cited by this paper
• [35] Radioimmunoassay of benzodiazepines

  1982cited by this paper
• Radioimmunoassay of benzodiazepines.

  1982cited by this paper

• Métodos instrumentales para la determinación de benzodiacepinas en muestra de orina: revisión sistemática de literatura

  2026cites this paper
• Development and Validation of an LC-MS/MS Method for the Simultaneous Determination of Alprazolam, Bromazepam, Clonazepam, Diazepam and Flunitrazpam in Human Urine and Its Application to Samples from Suspected Drug Abusers

  2025cites this paper
• Development and Validation of Confirmatory Quantitative and Screening Methods for 63 Prohibited Substances in Horse Urine Using LC–MS/MS

  2025cites this paper
• Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations

  2024cites this paper
• Electrochemical detection of nitrazepam using leaf-like graphitic carbon nitride nanosheets

  2023cites this paper
• Bridging the gap: The critical role of laboratory developed tests in clinical toxicology

  2023cites this paper
• Evaluation and improvement of a miniature mass spectrometry system for quantitative harm reduction drug checking

  2022cites this paper
• A Molecularly Imprinted Polymer as the Adsorbent for the Selective Determination of Oxazepam in Urine and Plasma Samples by High-Performance Liquid Chromatography with Diode Array Detection

  2021cites this paper
• The Analytical Performance of Six Urine Drug Screens on Cobas 6000 and ARCHITECT i2000 Compared to LC-MS/MS Gold Standard.

  2021cites this paper
• Systematic Evaluation and Validation of Benzodiazepines Confirmation Assay Using LC-MS-MS.

  2018cites this paper
• Quantitation of Benzodiazepines and Metabolites in Urine by Liquid Chromatography-Tandem Mass Spectrometry.

  2018cites this paper
• Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.

  2017cites this paper
• Immunoassay-Based Drug Tests Are Inadequately Sensitive for Medication Compliance Monitoring in Patients Treated for Chronic Pain.

  2017cites this paper
• Review: The Application of Liquid Chromatography Electrochemical Detection for the Determination of Drugs of Abuse

  2016cites this paper
• OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Review Articles Interpretation of Urine Drug Testing in Pain Patients

  2016cites this paper
• Prescription Sedative Misuse and Abuse

  2015cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.

  2014cites this paper
• Optimizing urine drug testing for monitoring medication compliance in pain management.

  2013cites this paper
• Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol Use

  2013cites this paper
• Simultaneous quantification of urine flunitrazepam, nimetazepam and nitrazepam by using liquid chromatography tandem mass spectrometry.

  2013cites this paper
• Direct urine analysis for the identification and quantification of selected benzodiazepines for toxicology screening.

  2012cites this paper
• Interpretation of urine drug testing in pain patients.

  2012cites this paper
• Table 2 List of prescription and illicit drugs commonly used in the pain population

  2012cites this paper
• LC-MS in analytical toxicology: some practical considerations.

  2011cites this paper
• Fragmentation of toxicologically relevant drugs in positive-ion liquid chromatography-tandem mass spectrometry.

  2011cites this paper
• A fast liquid chromatography-tandem mass spectrometry method for determining benzodiazepines and analogues in urine. Validation and application to real cases of forensic interest.

  2011cites this paper
• Screening for drugs of abuse: which matrix, oral fluid or urine?

  2011cites this paper
• Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.

  2011cites this paper